gain-of-function p53 mutants co-opt chromatin pathways drive cancer growth
tp53 encodes p53 protein frequently mutated gene among human cancers prevalent p53 missense mutations abrogate tumour suppressive function lead gain-of-function gof promotes cancer show p53 gof mutants bind upregulate chromatin regulatory genes including methyltransferases mll1 also known kmt2a mll2 also known kmt2d acetyltransferase moz also known kat6a myst3 resulting genome-wide increases histone methylation acetylation analysis cancer genome atlas shows specific upregulation mll1 mll2 moz p53 gof patient-derived tumours wild-type p53 p53 null tumours cancer cell proliferation markedly lowered genetic knockdown mll1 pharmacological inhibition mll1 methyltransferase complex study reveals novel chromatin mechanism underlying progression tumours gof p53 suggests new possibilities designing combinatorial chromatin-based therapies treating individual cancers driven prevalent gof p53 mutations
